Page 4 - Mark Fishman News Today

A trio of attorneys are now facing multiple felony charges on accusations of running a criminal enterprise to prey on some of the most vulnerable populations. A trio of attorneys are now facing multiple felony charges on accusations of running a criminal enterprise to prey on some of the most vulnerable populations. The Genesee County prosecutor is charging the attorneys out of Oakland County saying they would serve people as debt collectors and use the courts to garnish wages from victims who ...

Oakland County attorneys charged in alleged fraud scheme involving hundreds in 5 counties Only 7 Action News cameras are rolling early this morning outside the Fishman Group law office and three homes on Oakland County as they were raided by deputies and local police. By: Jim Kiertzner and last updated 2021-04-06 18:14:42-04 BLOOMFIELD HILLS, Mich. (WXYZ) — Only 7 Action News cameras are rolling early this morning outside the Fishman Group law office and three homes on Oak...

It has been a year now since the COVID-19 pandemic shut down the world as we know it. For Jews across the globe, that immediately impacted Passover Seders, the evenings that see families gather to tell the Biblical story of Exodus — where God freed the Israelites from slavery in Egypt – eat traditional and symbolic foods, and sing prayers and songs. Passover 2021 will begin on the evening of Saturday, March 27 and ends on the evening of Sunday, April 4. With the vaccination program ju...

Sosei Heptares Operational Highlights and Consolidated Results for the 12 Months ended 31 December 2020 News provided by Share this article Share this article TOKYO and CAMBRIDGE, England, Feb. 12, 2021 /PRNewswire/ -- Sosei Group Corporation ("the Company") (TSE: 4565) provides an update on operational activities and reports its consolidated results for the 12 months ended 31 December 2020. The full report can be accessed by clicking here.  Shinichi Tamura, Chairman, President and CEO of Sose...

by Barry Teater, NCBiotech writer — December 16, 2020 . RESEARCH TRIANGLE PARK – vTv Therapeutics of High Point has out-licensed worldwide development and commercialization rights to its potential kidney disease drug to a California biotech company in a deal that ultimately could be worth more than $150 million. Under the terms of the agreement, Anteris Bio will pay vTv $2 million up front and up to $151 million for future development, regulatory and commercial sales milestones, as well a...

Aditum Bio launches third company, Anteris Bio, in collaboration with TrialSpark - Aditum Bio "spin-out" companies such as Anteris Bio will leverage TrialSparks clinical development engine to rapidly advance their drug assets through clinical trials. News provided by Share this article Share this article NEW YORK, Dec. 16, 2020 /PRNewswire/ -- TrialSpark, a tech-enabled drug development partner committed to improving the speed, quality, and innovation of clinical trials, formally announces a c...

vTv Therapeutics Announces Licensing Agreement for Novel Nrf2 Activator to Anteris Bio HIGH POINT, N.C., Dec. 15, 2020 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq:VTVT) today announced that vTv Therapeutics LLC (“vTv”) has entered into a licensing agreement with Anteris Bio for worldwide rights to vTv’s novel clinical-stage Nrf2 activator compound, HPP971. Anteris Bio, a newly-formed portfolio company of Aditum Bio, the biotech investment firm co-founded in 2019 by former Novartis ...